| Elixinol Wellness Limited (EXL) ORDINARY FULLY PAID |
Consumer Staple |
$6 |
Repositioned for Sustainable Growth and Margin Expansion
|
27 Feb 2026 2:33PM |
$0.009 |
$0.015 |
risen by
66.67%
|
|
EXL - Price-sensitive ASX Announcement
Full Release
Key Points
- FY25 revenue of $15.5m, up 3.6% year-on-year.
- Significant growth in e-commerce sales in Australia, particularly from The Healthy Chef.
- Gross margin increased to 39%, with a Q4 increase to 42%.
- Positive adjusted EBITDA achieved in Q4 FY25.
- Capital management activities raised $4m to support growth.
- Challenges in the US market due to regulatory uncertainties.
- Focus on strengthening the business foundation and brand portfolio.
- Opportunities for growth in nutrition, wellness, and superfoods categories.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Aeris Environmental Ltd (AEI) ORDINARY FULLY PAID |
Industrials |
$9 |
Half Year Report & Appendix 4D
|
27 Feb 2026 2:33PM |
$0.043 |
$0.038 |
fallen by
11.63%
|
|
AEI - Price-sensitive ASX Announcement
Full Release
Key Points
- Total ordinary revenue for the half-year ended 31 December 2025 was $1,077,773.
- Net loss before tax for the half-year was $3,037,829.
- Significant expenses include cost of sales, employee benefits, and finance costs.
- Principal activities involve research and development of HVAC/R hygiene products.
- Financial flexibility maintained with $10,168,625 in loan facilities.
- Loss for the half-year attributable to owners was $2,619,653.
- Basic loss per share was 1.06 cents.
- Cash and cash equivalents at the end of the half-year were $1,443,780.
- Director's declaration confirms compliance with ASX Listing Rules.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Elixinol Wellness Limited (EXL) ORDINARY FULLY PAID |
Consumer Staple |
$6 |
FY25 Results Investor Presentation
|
27 Feb 2026 2:32PM |
$0.009 |
$0.015 |
risen by
66.67%
|
|
EXL - Price-sensitive ASX Announcement
Full Release
Key Points
- Elixinol Wellness reported $15.5 million revenue for FY25, a 3.6% increase YoY.
- Strong e-commerce growth in Australia with a 163% increase in sales.
- US revenue weakened due to CBD regulatory uncertainties.
- Gross margin improved to 39%, reaching 42% in Q4.
- Adjusted EBITDA loss was $3.4 million but turned positive in Q4.
- Operating expenses reduced by 30% in Q4 compared to Q4 FY24.
- Strategic focus on higher-margin categories and channels.
- New product launches and collaboration with Coles for innovation.
- Well-positioned for sustainable growth and M&A opportunities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Metal Powder Works Limited (MPW) ORDINARY FULLY PAID |
Industrials |
$309 |
Change in substantial holding
|
27 Feb 2026 2:32PM |
$2.780 |
$2.550 |
fallen by
8.27%
|
|
| Elixinol Wellness Limited (EXL) ORDINARY FULLY PAID |
Consumer Staple |
$6 |
Appendix 4G and Corporate Governance Statement
|
27 Feb 2026 2:32PM |
$0.009 |
$0.015 |
risen by
66.67%
|
|
| Titomic Limited (TTT) ORDINARY FULLY PAID |
Materials |
$377 |
Change in substantial holding
|
27 Feb 2026 2:32PM |
$0.205 |
$0.235 |
risen by
14.63%
|
|
| Elixinol Wellness Limited (EXL) ORDINARY FULLY PAID |
Consumer Staple |
$6 |
FY25 Appendix 4E and Annual Report
|
27 Feb 2026 2:31PM |
$0.009 |
$0.015 |
risen by
66.67%
|
|
EXL - Price-sensitive ASX Announcement
Full Release
Key Points
- Elixinol Wellness Limited reported a revenue of $15,500,000 for the year ended 31 December 2025.
- The company experienced a net loss after tax of $5,500,000.
- The report includes the allocation of share-based payments, options, and performance rights.
- Revenue from the Australian market was the largest contributor at $13,904,000.
- The company's total liabilities were reported as $8,512,000.
- Elixinol's impairment testing reveals a total impairment charge of $232,000.
- A terminal growth rate of 2.0% and a pre-tax discount rate of 23% were used in cash flow projections.
- The directors have not declared or paid any dividends during the financial year.
- Elixinol Wellness Limited's issued capital was $229,881,000 as at 31 December 2025.
- The financial year saw a share price decline, closing at $0.009 on 31 December 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Serko Limited (SKO) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Information Technology |
$150 |
Change in substantial holding
|
27 Feb 2026 2:31PM |
$1.950 |
$1.200 |
fallen by
38.46%
|
|
| Aurora Energy Metals Limited (1AE) ORDINARY FULLY PAID |
Materials |
$13 |
Change of Director's Interest Notice
|
27 Feb 2026 2:31PM |
$0.079 |
$0.073 |
fallen by
7.59%
|
|
| Forrestania Resources Limited (FRS) ORDINARY FULLY PAID |
Materials |
$781 |
Change of Director's Interest Notice - DG
|
27 Feb 2026 2:30PM |
$0.680 |
$0.605 |
fallen by
11.03%
|
|
| Great Dirt Resources Limited (GR8) ORDINARY FULLY PAID |
Materials |
$39 |
Half Yearly Report and Accounts
|
27 Feb 2026 2:29PM |
$0.600 |
$0.800 |
risen by
33.33%
|
|
| Forrestania Resources Limited (FRS) ORDINARY FULLY PAID |
Materials |
$781 |
Change of Director's Interest Notice - AT
|
27 Feb 2026 2:27PM |
$0.690 |
$0.605 |
fallen by
12.32%
|
|
| 4DS Memory Limited (4DS) ORDINARY FULLY PAID |
Information Technology |
$23 |
Appendix 4D & Half-Year Financial Statements
|
27 Feb 2026 2:26PM |
$0.013 |
$0.011 |
fallen by
12%
|
|
4DS - Price-sensitive ASX Announcement
Full Release
Key Points
- 4DS Memory Limited reported a loss of $914,658 for the half-year ended 31 December 2025, which is a decrease from the previous year's loss of $3,461,538.
- Total revenue from ordinary activities increased by 117.4% to $316,448.
- Research and development expenses were the largest portion of operating costs.
- No dividends were paid, recommended, or declared during the current and previous financial periods.
- Net tangible assets per ordinary security decreased to 0.37 cents from 0.43 cents.
- Significant management changes included the resignation of the Chief Strategy Officer and the Chief Technology Officer.
- Board and Executive remuneration adjustments were implemented, including a reduction of fees and salaries.
- The company is focusing on stabilizing business and preserving capital following the completion of its 20nm Sixth Platform Lot development program.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ionic Rare Earths Limited (IXR) ORDINARY FULLY PAID |
Materials |
$77 |
Proposed issue of securities - IXR
|
27 Feb 2026 2:24PM |
$0.415 |
$0.340 |
fallen by
18.07%
|
|
| Carbonxt Group Limited (CG1) ORDINARY FULLY PAID |
Materials |
$32 |
HY26 Results Announcement
|
27 Feb 2026 2:24PM |
$0.090 |
$0.073 |
fallen by
18.89%
|
|
CG1 - Price-sensitive ASX Announcement
Full Release
Key Points
- HY26 revenue totaled $8.50m, representing a 15.7% increase from HY25.
- Kentucky activated carbon facility advanced toward commercial output.
- Gross margin improved to 54% from 49% in the previous period.
- Operating costs were well managed, leading to positive cash inflow.
- Carbonxt increased ownership in New Carbon Processing, LLC to 46.7%.
- Regulatory momentum supports ongoing demand in core markets.
- Challenges were faced due to maintenance outages impacting ACP deliveries.
- Financial position includes a secured facility with Pure Asset Management.
- Material uncertainty related to going concern due to covenant breaches.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Light & Wonder Inc. (LNW) CHESS DEPOSITARY INTERESTS 1:1 |
Consumer Discretionary |
$9,255 |
LNW Form 144s (trades by retired KMP)
|
27 Feb 2026 2:23PM |
$134.960 |
$114.000 |
fallen by
15.53%
|
|
| Carbonxt Group Limited (CG1) ORDINARY FULLY PAID |
Materials |
$32 |
Half Yearly Report and Accounts
|
27 Feb 2026 2:22PM |
$0.090 |
$0.073 |
fallen by
18.89%
|
|
CG1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Total comprehensive loss for the half-year: $4,551,759
- Net loss after tax: $3,971,198
- Revenue increased by 15.7% to $8,503,509
- Increased demand from the largest PAC customer
- Breached financial covenants related to the Pure Loan Facility
- Material uncertainty regarding going concern
- No dividends declared
- Increased stake in NewCarbon Processing, LLC to 45.95%
- Strategic plans to improve cash flows and secure additional funding
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Senetas Corporation Limited (SEN) ORDINARY FULLY PAID |
Information Technology |
$42 |
Senetas CEO Investor Presentation
|
27 Feb 2026 2:20PM |
$2.100 |
$2.530 |
risen by
20.48%
|
|
SEN - Price-sensitive ASX Announcement
Full Release
Key Points
- Senetas provides high-assurance cybersecurity solutions globally.
- Focus on quantum-resistant network encryption and secure file sharing.
- Revenue consistent for half-year ending December 2025.
- Delays in Middle Eastern sales due to export permit issues.
- Alliances with companies like Nokia for mission-critical environments.
- Strong focus on R&D, including post-quantum encryption capabilities.
- Projected revenue and profit growth in FY2026.
- Significant indirect investment in Menlo Security Inc.
- Company remains debt-free with a strong cash position.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Burgundy Diamond Mines Limited (BDM) ORDINARY FULLY PAID |
Materials |
$24 |
Preliminary Final Report
|
27 Feb 2026 2:20PM |
$0.017 |
$0.017 |
fallen by
0%
|
|
| PainChek Ltd (PCK) ORDINARY FULLY PAID |
Health Care |
$28 |
Half Yearly Report and Accounts
|
27 Feb 2026 2:19PM |
$0.170 |
$0.135 |
fallen by
20.59%
|
|
PCK - Price-sensitive ASX Announcement
Full Release
Key Points
- Net loss for the period was AUD 4.7 million.
- Revenue increased to AUD 1.73 million.
- FDA De Novo clearance received for the Adult App in the US.
- Significant market access and reimbursement potential in the US.
- Continued investment in strategic R&D and integration initiatives.
- Performance rights granted to directors and CEO.
- Ongoing clinical validation studies and market expansion.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Bridge SaaS Limited (BGE) ORDINARY FULLY PAID |
Information Technology |
$3 |
Appendix 4D and Half Year Reports 31 Dec 2025
|
27 Feb 2026 2:18PM |
$0.015 |
$0.013 |
fallen by
13.33%
|
|
BGE - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased by 83.7% to $5,658,745.
- Loss reduced by 71.9% to $156,036.
- Strategic expansion in disability services with new operations in New South Wales.
- Brightside operations demonstrate continued growth and stability.
- Material uncertainty regarding going concern status due to liabilities exceeding assets.
- Directors optimistic about future operations citing profitable subsidiaries and cost reductions.
- Auditor's review highlights going concern uncertainty but no significant issues.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Vista Group International Limited (VGL) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Information Technology |
$413 |
FY2025 Result Presentation Recording & Transcript
|
27 Feb 2026 2:18PM |
$1.580 |
$1.725 |
risen by
9.18%
|
|
| Income Asset Management Group Limited (IAM) ORDINARY FULLY PAID |
Financials |
$19 |
Half Year Accounts
|
27 Feb 2026 2:17PM |
$0.022 |
$0.020 |
fallen by
9.09%
|
|
IAM - Price-sensitive ASX Announcement
Full Release
Key Points
- Total comprehensive loss amounted to AUD 3,022,220.
- Net operating cash outflows were reported at AUD 2,725,321.
- Net cash flows from financing activities totaled AUD 1,857,921.
- A two million AUD debt facility was established with a maturity date of 1 July 2027.
- Restatements were made to correct previously reported figures.
- Equity decreased to AUD 1,144,696 from the previous year.
- Share-based payments and performance rights were outlined in the financials.
- Basic and diluted earnings per share were both reported as negative for the period.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Phoslock Environmental Technologies Limited (PET) ORDINARY FULLY PAID |
Industrials |
$5 |
Appendix 4G and Corporate Governance Statement
|
27 Feb 2026 2:16PM |
$0.014 |
$0.008 |
fallen by
42.86%
|
|
| Phoslock Environmental Technologies Limited (PET) ORDINARY FULLY PAID |
Industrials |
$5 |
Full Year Statutory Accounts
|
27 Feb 2026 2:15PM |
$0.014 |
$0.008 |
fallen by
42.86%
|
|
PET - Price-sensitive ASX Announcement
Full Release
Key Points
- Phoslock Environmental Technologies Limited reported a net loss of $3.253 million for 2025.
- Total revenue increased to $3.095 million, primarily in the US/Canada/Brazil region.
- Total assets were $8.438 million with net assets of $6.819 million.
- Accumulated losses increased to $86.471 million.
- No share-based compensations were issued during 2025.
- Deferred tax assets were not recognized due to uncertain recovery.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
